Macroprolactinomas [neop]
Objective [inpr]
Management [ocac]
Macroprolactinomas [neop]
Changed [ftcn]
Decade [qnco]
Surgical [hlca]
Medical [ftcn]
treatment [ftcn]
First-Line Therapy [topp]
Dopamine Agonists [phsu]
Few [qnco]
Exist [cnce]
Patients [podg]
Patients [podg]
Methods [inpr]
retrospective [resa]
Descriptive [idcn]
Multicenter Study [resa]
Patients [podg]
Macroprolactinoma [neop]
Hospitals, University [hcro, mnob]
Eight [qnco]
Patients [podg]
included [ftcn]
Men [popg]
Hypopituitarism [dsyn]
Patients [podg]
Serum prolactin level [lbpr]
mU/L [qnco]
Patients [podg]
Received [qlco]
Medical [ftcn]
treatment [ftcn]
Additional Surgery [topp]
Surgery [bmod]
radiotherapy [inpr]
Duration [tmco]
months [tmco]
End [spco]
Patients [podg]
Cured [cnce]
i e [diap, inpr]
normal prolactin level [fndg]
Normal [qlco]
Imaging [diap]
symptoms [ftcn]
Withdrawal [acty]
Dopamine Agonists [phsu]
Controlled [ftcn]
i e [diap, inpr]
normal prolactin level [fndg]
Normal [qlco]
Abnormal [qlco]
Imaging [diap]
symptoms [ftcn]
Dopamine Agonists [phsu]
In progress [ftcn]
Uncontrolled [qlco]
Uncontrolled [qlco]
Patients [podg]
Significance Level [resa]
high prolactin [fndg]
baseline [bodm]
P NOS [aapp, imft]
cabergoline [orch, phsu]
Cumulative Dose [cnce]
P NOS [aapp, imft]
Compared [acty]
Controlled [ftcn]
Group [idcn]
frequency [qnco]
Hypopituitarism [dsyn]
Valvular heart disease [dsyn]
Patients [podg]
Screening [hlca]
systematic [ftcn]
Conclusions [idcn]
Macroprolactinoma [neop]
Currently [tmco]
Often [tmco]
Chronic disease [dsyn]
Controlled [ftcn]
Dopamine Agonists [phsu]
Uncertainty [idcn]
adverse effects [ftcn]
High dose [qnco]
Cumulative [qlco]
lack [qlco]
Very [qlco]
Current [tmco]
strategies [menp]
Including [ftcn]
Surgery [bmod]
Combined [qlco]
Medical [ftcn]
treatment [ftcn]
SAS [orch]
Reserve [acty]
